LA
LIMNW

Linden Advisors’s Liminatus Pharma Warrants LIMNW Stock Holding History

Linden Advisors’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1K Hold
268,199
– – ﹤0.01% 549
2025
Q4 		$10.6K Hold
268,199
– – ﹤0.01% 460
2025
Q3 		$39.7K Hold
268,199
– – ﹤0.01% 378
2025
Q2 		$56.3K Buy
+268,199
New +$52.7K ﹤0.01% 336

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Linden Advisors's LIMNW Position: Q1 2026 in Review

Linden Advisors held its Liminatus Pharma Warrants (LIMNW) position steady in Q1 2026 at 268,199 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Linden Advisors first reported a position in LIMNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $56.3K in Q2 2025. 21 funds tracked by Wall St. Rank hold LIMNW as of Q1 2026.

  • Linden Advisors held 268,199 shares of Liminatus Pharma Warrants worth $13.1K as of Q1 2026.
  • Linden Advisors left its Liminatus Pharma Warrants share count unchanged in Q1 2026.
  • Liminatus Pharma Warrants made up ﹤0.01% of Linden Advisors's portfolio in Q1 2026, its #549 holding.
  • Linden Advisors first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 4 quarters since.
  • Linden Advisors's Liminatus Pharma Warrants position peaked at $56.3K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.